- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Galmed Pharmaceuticals Ltd (GLMD)
Assess today's live Galmed Pharmaceuticals Ltd (GLMD) share price, performance and insights using our live NASDAQ: GLMD stock exchange data.
Analyse the historical data and Galmed Pharmaceuticals Ltd share price performance charts on this page. Our technical summary section provides analysis on Galmed Pharma share price buy/sell indicators using real-time data (or discuss the Galmed Pharma (GLMD) stock price today with other investors in the Galmed Pharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ GLMD share price (ISIN: IL0011313900) to enhance your trading decisions with our free investment tools and resources.
What Is the Galmed Pharmaceuticals Ltd Share Price Today?
The Galmed Pharma share price today is 0.673.
What Is the Stock Symbol for Galmed Pharmaceuticals Ltd
The stock symbol (or 'ticker') for Galmed Pharmaceuticals Ltd is "GLMD."
What Stock Exchange Does Galmed Pharmaceuticals Ltd Trade On?
Galmed Pharmaceuticals Ltd is listed and trades on the NASDAQ stock exchange.
Is Galmed Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Galmed Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Galmed Pharmaceuticals Ltd share price performance charts on this page. Our technical summary section provides analysis on Galmed Pharma share price buy/sell indicators using real-time data (or discuss the Galmed Pharma (GLMD) stock price today with other investors in the Galmed Pharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ GLMD share price (ISIN: IL0011313900) to enhance your trading decisions with our free investment tools and resources.
What Is the Galmed Pharmaceuticals Ltd Share Price Today?
The Galmed Pharma share price today is 0.673.
What Is the Stock Symbol for Galmed Pharmaceuticals Ltd
The stock symbol (or 'ticker') for Galmed Pharmaceuticals Ltd is "GLMD."
What Stock Exchange Does Galmed Pharmaceuticals Ltd Trade On?
Galmed Pharmaceuticals Ltd is listed and trades on the NASDAQ stock exchange.
Is Galmed Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Galmed Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.650
0.718
52 wk Range
0.411
2.680
GLMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.6500.718
52 wk Range
0.4112.680
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GLMD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 6K Galmed Pharmaceuticals Ltd For: 30 January
- Investing.com
- Form 6K Galmed Pharmaceuticals Ltd For: 9 April
- Investing.com
- Form 6K Galmed Pharmaceuticals Ltd For: 9 April
- Investing.com
- Form 6K Galmed Pharmaceuticals Ltd. For: 5 March
- Investing.com
- Form 6K Galmed Pharmaceuticals Ltd. For: 4 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.
Compare GLMD to Peers and Sector
Metrics to compare | GLMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGLMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −4.0x | −0.5x | |
PEG Ratio | −0.01 | −0.10 | 0.00 | |
Price/Book | 0.3x | 1.6x | 2.6x | |
Price / LTM Sales | - | 105.0x | 3.2x | |
Upside (Analyst Target) | - | 80.0% | 45.2% | |
Fair Value Upside | Unlock | 6.2% | 6.4% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.000
Earnings
Latest Release
01/04/2026
EPS / Forecast
-0.80 / -0.51
Revenue / Forecast
-- / 1.3M
People Also Watch
FAQ
What Is the Galmed Pharma (NASDAQ: GLMD) Share Price Today?
The Galmed Pharma stock price today is 0.673 USD.
What Stock Exchange Does Galmed Pharma (GLMD) Trade On?
Galmed Pharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Galmed Pharma?
The stock symbol (also called a 'ticker') for Galmed Pharma is "GLMD."
What Is the Current Galmed Pharma Market Capitalisation?
As of today, Galmed Pharma (NASDAQ: GLMD) market cap is 4.430M USD.
What Is Galmed Pharma's (GLMD) Earnings Per Share (TTM)?
The Galmed Pharma EPS is currently -2.391 (Trailing Twelve Months).
When Is the Next Galmed Pharma Earnings Date?
Galmed Pharma's next earnings report will be released on 20/05/2026.
Is GLMD a Buy or Sell From a Technical Analyst Perspective?
Based on today's Galmed Pharma moving averages and other technical indicators, the daily buy/sell signal for GLMD stock is Strong Sell.
How Many Times Has Galmed Pharma Stock Split?
Galmed Pharma has split 2 times. (See the GLMD stock split history page for full effective split date and price information.)
How Many Employees Does Galmed Pharma Have?
Galmed Pharma has 5 employees, based on their latest Companies House report.
What is the current trading status of Galmed Pharma (NASDAQ: GLMD)?
As of 23/04/2026, Galmed Pharma (GLMD) is trading at a share price of 0.673 USD, with a previous close of 0.673 USD. The stock has fluctuated within a day range of 0.650 USD to 0.718 USD, while its 52-week range spans from 0.411 USD to 2.680 USD.
What Is the GLMD Premarket Price?
GLMD's last pre-market stock price is 0.660 USD. The pre-market share volume is 6,870.000, and the stock has decreased by -0.013, or -1.930%.
What Is the GLMD After Hours Price?
GLMD's last after hours stock price is 0.652 USD, the stock has decreased by -0.020, or -3.020%.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.